Combining Serum Interleukin-6 and other Inflammatory Biomarkers to Improve the Prediction of COVID-19 Severity

The role of laboratory markers as predictors of severity in Covid 19 patients

Serum Soluble Interleukin–2 Receptor Alpha and RANTES Chemokine as Potential Biomarkers for COVID–19 Infection and Severity

Correlating COVID-19 Infection Severity and Prognosis with Cytokines Level

Potential Diagnostic and Prognostic Values of Hematological Biomarkers in COVID-19‎ ‎

C-reactive protein as an early marker of severity and outcome in patients with SARS-CoV-2 infection

The Role of Procalcitonin and Serum Amyloid a As a Laboratory Biomarker in COVID-19

CD177, S100A8 and S100A12 as Markers of Severity in COVID- 19 Patients

Comparative study of Some biochemical and Immunological parameters of patients with COVID-19 disease and non-infected people

Prognostic value of Procalcitonin and Interleukin 6 in COVID-19 patients